NCT02285504View on ClinicalTrials.gov

Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 7, 2015

Primary Completion Date

June 5, 2015

Study Completion Date

June 5, 2015

Conditions
Postpartum Depression
Interventions
DRUG

SAGE-547

Intravenous injection

Trial Locations (1)

27514

Sage Investigational Site, Chapel Hill

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY

NCT02285504 - Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression | Biotech Hunter | Biotech Hunter